Exhibit 10.195
EXECUTION VERSION

SUPPLEMENTAL INDENTURE
SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of July 10,
2014, among Endo Netherlands B.V. (the “Guaranteeing Subsidiary”), a subsidiary
of Endo Limited, a private limited company incorporated under the laws of
Ireland (the “Company”), the Issuers, the other Guarantors (both, as defined in
the Indenture referred to below) and Wells Fargo Bank, National Association, as
trustee under the Indenture referred to below (the “Trustee”).
W I T N E S S E T H
WHEREAS, Endo Finance LLC, a Delaware limited liability company, and Endo Finco
Inc., a Delaware corporation, have heretofore executed and delivered to the
Trustee an indenture, dated as of May 6, 2014, as supplemented by a supplemental
indenture, dated as of May 28, 2014, among the Issuers, the Guarantors party
thereto and the Trustee (as so supplemented, the “Indenture”), providing for the
issuance of 7.25% Senior Notes due 2022 (the “Notes”);
WHEREAS, the Indenture provides that under certain circumstances the
Guaranteeing Subsidiary shall execute and deliver to the Trustee a supplemental
indenture pursuant to which the Guaranteeing Subsidiary shall unconditionally
guarantee all of the Issuers’ Obligations under the Notes and the Indenture on
the terms and conditions set forth herein (the “Note Guarantee”);
WHEREAS, this Supplemental Indenture has not resulted in a material modification
of the Notes for Foreign Account Tax Compliance Act purposes; and
WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to
execute and deliver this Supplemental Indenture.
NOW, THEREFORE, in consideration of the foregoing and for other good and
valuable consideration, the receipt of which is hereby acknowledged, the
Guaranteeing Subsidiary and the Trustee mutually covenant and agree for the
equal and ratable benefit of the Holders of the Notes as follows:
1.    CAPITALIZED TERMS. Capitalized terms used herein without definition shall
have the meanings assigned to them in the Indenture.
2.    AGREEMENT TO GUARANTEE. The Guaranteeing Subsidiary hereby agrees to
provide an unconditional Guarantee on the terms and subject to the conditions
set forth in the Note Guarantee and in the Indenture including but not limited
to Article 10 thereof.
4.    NO RECOURSE AGAINST OTHERS. No director, officer, employee, incorporator
or stockholder of the Issuers or any Guarantor, as such, will have any liability
for any obligations of the Issuers or the Guarantors under the Notes, the
Indenture, this Supplemental Indenture, the Note Guarantees or for any claim
based on, in respect of, or by reason of, such obligations or their creation.
Each Holder of Notes by accepting a Note waives and releases all such liability.
The waiver and release are part of the consideration for issuance of the Notes.
The waiver may not be effective to waive liabilities under the federal
securities laws.
5.    NEW YORK LAW TO GOVERN; WAIVER OF JURY TRIAL. THIS SUPPLEMENTAL INDENTURE
SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF
NEW YORK. EACH OF THE ISSUERS

--------------------------------------------------------------------------------

Exhibit 10.195
EXECUTION VERSION

AND THE GUARANTORS CONSENTS AND IRREVOCABLY SUBMITS TO THE JURISDICTION OF ANY
NEW YORK STATE OR U.S. FEDERAL COURT LOCATED IN THE BOROUGH OF MANHATTAN, CITY
OF NEW YORK, COUNTY OF NEW YORK, STATE OF NEW YORK IN RELATION TO ANY LEGAL
ACTION OR PROCEEDING (I) ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS
INDENTURE, AS SUPPLEMENTED, THE NOTES, THE GUARANTEES AND ANY RELATED DOCUMENTS
AND/OR (II) ARISING UNDER ANY U.S. FEDERAL OR U.S. STATE SECURITIES LAWS IN
RESPECT OF THE NOTES, THE GUARANTEES AND ANY SECURITIES ISSUED PURSUANT TO THE
TERMS OF THE INDENTURE, AS SUPPLEMENTED. EACH OF THE ISSUERS AND THE GUARANTORS
WAIVES ANY OBJECTION TO PROCEEDINGS IN ANY SUCH COURTS, WHETHER ON THE GROUND OF
VENUE OR ON THE GROUND THAT THE PROCEEDINGS HAVE BEEN BROUGHT IN AN INCONVENIENT
FORUM. EACH OF THE ISSUERS AND THE GUARANTORS, TO THE EXTENT ORGANIZED OUTSIDE
OF THE UNITED STATES, SHALL APPOINT CT CORPORATION SYSTEM, 111 EIGHTH AVENUE,
13TH FLOOR, NEW YORK, NY 10011, AS ITS AGENT FOR SERVICE OF PROCESS IN ANY SUCH
SUIT, ACTION OR PROCEEDING AND AGREES THAT SERVICE OF PROCESS UPON SAID
AUTHORIZED AGENT SHALL BE DEEMED IN EVERY RESPECT EFFECTIVE SERVICE OF PROCESS
UPON IT IN ANY SUCH SUIT, ACTION OR PROCEEDING. EACH OF THE ISSUERS AND THE
GUARANTORS AGREES TO DELIVER, UPON THE EXECUTION AND DELIVERY OF THIS
SUPPLEMENTAL INDENTURE, A WRITTEN ACCEPTANCE BY SUCH AGENT OF ITS APPOINTMENT AS
SUCH AGENT. EACH OF THE ISSUERS AND THE GUARANTORS, TO THE EXTENT ORGANIZED
OUTSIDE OF THE UNITED STATES, FURTHER AGREES TO TAKE ANY AND ALL ACTION,
INCLUDING THE FILING OF ANY AND ALL SUCH DOCUMENTS AND INSTRUMENTS, AS MAY BE
REASONABLY NECESSARY TO CONTINUE SUCH DESIGNATION AND APPOINTMENT OF CT
CORPORATION SYSTEM IN FULL FORCE AND EFFECT FOR SO LONG AS THE INDENTURE, AS
SUPPLEMENTED, REMAINS IN FORCE. EACH OF THE ISSUERS, THE TRUSTEE AND THE
GUARANTORS HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY
APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING
ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE NOTES OR THE
TRANSACTIONS CONTEMPLATED HEREBY.
6.    COUNTERPARTS. The parties may sign any number of copies of this
Supplemental Indenture. Each signed copy (which may be provided via facsimile or
other electronic transmission) shall be an original, but all of them together
represent the same agreement.
7.    EFFECT OF HEADINGS. The Section headings herein are for convenience only
and shall not affect the construction hereof.
8.    THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever
for or in respect of the validity or sufficiency of this Supplemental Indenture
or for or in respect of the recitals contained herein, all of which recitals are
made solely by the Guaranteeing Subsidiary and the Issuers.

--------------------------------------------------------------------------------

Exhibit 10.195
EXECUTION VERSION

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture
to be duly executed and attested, all as of the date first above written.
 
ENDO NETHERLANDS B.V., as Guaranteeing Subsidiary

 
 
 
By:
/s/ Blaine Davis     
 
Name:
Blaine Davis 
 
Title:
Managing Director A
 
 
 
By:
/s/ Gert Jan Rietberg     
 
Name:
Gert Jan Rietberg
 
Title:
Managing Director B

[Signature Page to 7.25% Notes due 2022 Supplemental Indenture]

--------------------------------------------------------------------------------

Exhibit 10.195
EXECUTION VERSION

ENDO FINANCE LLC
  as an Issuer
 
by ENDO LUXEMBOURG FINANCE COMPANY I
S.À R.L., its sole member
 
 
 
By:
/s/ Andrew O'Shea
 
Name:
Andrew O'Shea
 
Title:
B Manager

[Signature Page to 7.25% Notes due 2022 Supplemental Indenture]

--------------------------------------------------------------------------------

Exhibit 10.195
EXECUTION VERSION

ENDO FINCO INC.
  as an Issuer
 
 
 
By:
/s/ Deanna Voss
 
Name:
Deanna Voss
 
Title:
Secretary

[Signature Page to 7.25% Notes due 2022 Supplemental Indenture]

--------------------------------------------------------------------------------

Exhibit 10.195
EXECUTION VERSION

ENDO LLC
ENDO U.S. INC. 
  each, as a Guarantor
 
 
 
By:
/s/ Deanna Voss
 
Name:
Deanna Voss
 
Title:
Secretary

[Signature Page to 7.25% Notes due 2022 Supplemental Indenture]

--------------------------------------------------------------------------------

Exhibit 10.195
EXECUTION VERSION

ENDO HEALTH SOLUTIONS INC.
ENDO PHARMACEUTICALS INC.
ENDO PHARMACEUTICALS SOLUTIONS INC.
ENDO PHARMACEUTICALS VALERA INC.
GENERICS INTERNATIONAL (US PARENT), INC.
GENERICS INTERNATIONAL (US MIDCO), INC.
GENERICS INTERNATIONAL (US HOLDCO), INC.
GENERICS INTERNATIONAL (US), INC.
AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.
AMERICAN MEDICAL SYSTEMS, INC.
AMS RESEARCH CORPORATION
AMS SALES CORPORATION
LASERSCOPE 
  each, as a Guarantor
 
 
 
By:
/s/ Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary

[Signature Page to 7.25% Notes due 2022 Supplemental Indenture]

--------------------------------------------------------------------------------

Exhibit 10.195
EXECUTION VERSION

GENERICS BIDCO I, LLC
VINTAGE PHARMACEUTICALS, LLC
GENERICS BIDCO II, LLC
MOORES MILL PROPERTIES LLC
WOOD PARK PROPERTIES LLC
QUARTZ SPECIALTY PHARMACEUTICALS, LLC 
  each, as a Guarantor
  by GENERICS INTERNATIONAL (US), INC.,
its manager
  
 
 
By:
/s/ Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary

[Signature Page to 7.25% Notes due 2022 Supplemental Indenture]

--------------------------------------------------------------------------------

Exhibit 10.195
EXECUTION VERSION

LEDGEMONT ROYALTY SUB LLC 
  as a Guarantor
  by ENDO PHARMACEUTICALS SOLUTIONS INC.,
  its manager
  
 
 
By:
/s/ Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary

[Signature Page to 7.25% Notes due 2022 Supplemental Indenture]

--------------------------------------------------------------------------------

Exhibit 10.195
EXECUTION VERSION

ENDO LIMITED
  as a Guarantor
 
 
 
By:
/s/ Blaine Davis     
 
Name:
Blaine Davis 
 
Title:
Attorney

ENDO VENTURES LIMITED
  as a Guarantor
 
 
 
By:
/s/ Blaine Davis     
 
Name:
Blaine Davis 
 
Title:
Attorney

ENDO MANAGEMENT LIMITED
  as a Guarantor
 
 
 
By:
/s/ Blaine Davis     
 
Name:
Blaine Davis 
 
Title:
Attorney

ENDO FINANCE LIMITED
  as a Guarantor
 
 
 
By:
/s/ Blaine Davis     
 
Name:
Blaine Davis 
 
Title:
Attorney

[Signature Page to 7.25% Notes due 2022 Supplemental Indenture]

--------------------------------------------------------------------------------

Exhibit 10.195
EXECUTION VERSION

ENDO LUXEMBOURG HOLDING COMPANY S.À R.L.
  as a Guarantor
 
 
 
By:
/s/ Andrew O'Shea     
 
Name:
Andrew O'Shea
 
Title:
B Manager

ENDO LUXEMBOURG FINANCE COMPANY I S.À R.L.
  as a Guarantor
 
 
 
By:
/s/ Andrew O'Shea     
 
Name:
Andrew O'Shea
 
Title:
B Manager

ENDO LUXEMBOURG FINANCE COMPANY II S.À R.L.
  as a Guarantor
 
 
 
By:
/s/ Andrew O'Shea     
 
Name:
Andrew O'Shea
 
Title:
B Manager

[Signature Page to 7.25% Notes due 2022 Supplemental Indenture]

--------------------------------------------------------------------------------

Exhibit 10.195
EXECUTION VERSION

PALADIN LABS CANADIAN HOLDING INC. 
  as a Guarantor
 
 
 
By:
/s/ Mark Beaudet     
 
Name:
Mark Beaudet
 
Title:
President

PALADIN LABS INC. 
  as a Guarantor
 
 
 
By:
/s/ Mark Beaudet     
 
Name:
Mark Beaudet
 
Title:
President

[Signature Page to 7.25% Notes due 2022 Supplemental Indenture]

--------------------------------------------------------------------------------

Exhibit 10.195
EXECUTION VERSION

ENDO VENTURES BERMUDA LIMITED, as a Guarantor 

 
 
 
By:
/s/ Robert Rush     
 
Name:
Robert Rush
 
Title:
Director

[Signature Page to 7.25% Notes due 2022 Supplemental Indenture]

--------------------------------------------------------------------------------

Exhibit 10.195
EXECUTION VERSION

WELLS FARGO BANK, NATIONAL ASSOCIATION,
  as Trustee
 
 
 
By:
/s/ Martin Reed     
 
Name:
Martin Reed
 
Title:
Vice President

[Signature Page to 7.25% Notes due 2022 Supplemental Indenture]